Dr Dao Nguyen examines a vial of lutein formulation developed for potential use in eyedrop treatments. Credit: Will Wright, RMIT UniversityResearchers at RMIT University have developed an experimental eyedrop formula that could transform the treatment of serious retinal conditions, including age-related macular degeneration (AMD). AMD, a leading cause of blindness worldwide, damages the macula in the retina, with risk factors including age, genetics, diet, high blood pressure, obesity and smoking. Modern exposure to high-energy blue […] The post New eyedrop shows promise to treat retinal conditions appeared first on Manufacturers' Monthly.